Evotec - Research never stops

P2X3 and P2X2/3 Antagonists

Involvement of P2X2/3 receptors in pain pathways and urological disease has been convincingly demonstrated in gene disruption studies. Evotec has identified promising lead molecules across different chemical series and demonstrated in vivo activity.